Impact of an integrated community case management programme on uptake of appropriate diarrhoea and pneumonia treatments in Uganda: A propensity score matching and equity analysis study

International Journal for Equity in Health
Agnes NanyonjoKarin Källander

Abstract

Pneumonia and diarrhoea disproportionately affect children in resource-poor settings. Integrated community case management (iCCM) involves community health workers treating diarrhoea, pneumonia and malaria. Studies on impact of iCCM on appropriate treatment and its effects on equity in access to the same are limited. The objective of this study was to measure the impact of integrated community case management (iCCM) as the first point of care on uptake of appropriate treatment for children with a classification of pneumonia (cough and fast breathing) and/or diarrhoea and to measure the magnitude and distribution of socioeconomic status related inequality in use of iCCM. Following introduction of iCCM, data from cross-sectional household surveys were examined for socioeconomic inequalities in uptake of treatment and use of iCCM among children with a classification of pneumonia or diarrhoea using the Erreygers' corrected concentration index (CCI). Propensity score matching methods were used to estimate the average treatment effects on the treated (ATT) for children treated under the iCCM programme with recommended antibiotics for pneumonia, and ORS plus or minus zinc for diarrhoea. Overall, more children treated under iCCM receiv...Continue Reading

Associated Clinical Trials

References

Feb 12, 1998·Annals of Internal Medicine·D B Rubin
Feb 25, 2003·Lancet·Joanna Armstrong SchellenbergUNKNOWN Tanzania Integrated Management of Childhood Illness MCE Baseline Household Survey Study Group
Jul 11, 2003·Lancet·Gareth JonesUNKNOWN Bellagio Child Survival Study Group
Sep 5, 2003·The Lancet Infectious Diseases·Sunil SazawalUNKNOWN Pneumonia Case Management Trials Group
Sep 24, 2004·Pharmacoepidemiology and Drug Safety·Donald B Rubin
Aug 27, 2005·The Lancet Infectious Diseases·Iruka N OkekeRamanan Laxminarayan
Oct 13, 2006·Health Policy and Planning·Seema Vyas, Lilani Kumaranayake
Oct 20, 2007·Transactions of the Royal Society of Tropical Medicine and Hygiene·Jesca Nsungwa-SabiitiGoran Tomson
Mar 28, 2008·Journal of Health Economics·Guido Erreygers
Jun 12, 2008·Bulletin of the World Health Organization·David R MarshShamim Qazi
Apr 2, 2010·International Journal of Epidemiology·Evropi TheodoratouHarry Campbell
Nov 8, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·E M A SmetsM I van Berge Henegouwen
Mar 31, 2012·Bulletin of the World Health Organization·Alexandra de SousaDavidson H Hamer
Mar 26, 2013·Journal of Health Economics·Gustav Kjellsson, Ulf-G Gerdtham
Apr 16, 2013·Lancet·Zulfiqar A BhuttaUNKNOWN Lancet Diarrhoea and Pneumonia Interventions Study Group
Nov 8, 2013·Archives of Disease in Childhood·Carla Chan UngerShams El Arifeen
Dec 29, 2013·Health Policy and Planning·Thomas DruetzSlim Haddad

❮ Previous
Next ❯

Software Mentioned

STATA
iCCM

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.